The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation

Cell Signaling by Receptor Tyrosine Kinases

Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929 · see citing works

AKT/PKB signaling: navigating downstream

Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115 · see citing works

mTOR: from growth signal integration to cancer, diabetes and ageing

Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941 · see citing works

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Flaherty, K. T., Puzanov, I. J., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,542 · see citing works

MAP kinase signalling pathways in cancer

Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210421 · Cited by 2,995 · see citing works

Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL

Zha, J., Harada, H., Yang, E., Jockel, J., & Korsmeyer, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81382-3 · Cited by 2,578 · see citing works

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

Nazarian, R., Shi, H., Wang, Q., Kong, X., Koya, R. C., Lee, H., Chen, Z., Lee, M., Attar, N., Sazegar, H., et al. (2010) · Nature · doi:10.1038/nature09626 · Cited by 2,198 · see citing works

Phosphatidylinositol-3-OH kinase direct target of Ras

Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., & Downward, J. (1994) · Nature · doi:10.1038/370527a0 · Cited by 1,954 · see citing works

Cell Survival Promoted by the Ras-MAPK Signaling Pathway by Transcription-Dependent and -Independent Mechanisms

Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., & Greenberg, M. E. (1999) · Science · doi:10.1126/science.286.5443.1358 · Cited by 1,887 · see citing works

COT drives resistance to RAF inhibition through MAP kinase pathway reactivation

Johannessen, C. M., Boehm, J. S., Kim, S. Y., Thomas, S. R., Wardwell, L., Johnson, L. A., Emery, C. M., Stransky, N., Cogdill, A. P., Barretina, J., et al. (2010) · Nature · doi:10.1038/nature09627 · Cited by 1,460 · see citing works

Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer

Carracedo, A., Ma, L., Teruya-Feldstein, J., Rojo, F., Salmena, L., Alimonti, A., Egia, A., Sasaki, A. T., Thomas, G., Kozma, S. C., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34739 · Cited by 1,381 · see citing works

Multiple Ras-dependent phosphorylation pathways regulate Myc protein stabilityPreprint

Sears, R. C., Nuckolls, F., Haura, E. B., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,379 · see citing works

Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers

Engelman, J. A., Chen, L., Tan, X., Crosby, K., Guimaraes, A. R., Upadhyay, R., Maira, M., McNamara, K., Perera, S. A., Song, Y., et al. (2008) · Nature Medicine · doi:10.1038/nm.1890 · Cited by 1,330 · see citing works

FOXO transcription factors at the interface between longevity and tumor suppression

Greer, E. L., & Brunet, A. (2005) · Oncogene · doi:10.1038/sj.onc.1209086 · Cited by 1,306 · see citing works

The nuts and bolts of AGC protein kinases

Pearce, L. R., Komander, D., & Alessi, D. R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2822 · Cited by 1,294 · see citing works

mTOR and S6K1 Mediate Assembly of the Translation Preinitiation Complex through Dynamic Protein Interchange and Ordered Phosphorylation Events

Holz, M. K., Ballif, B. A., Gygi, S. P., & Blenis, J. (2005) · Cell · doi:10.1016/j.cell.2005.10.024 · Cited by 1,262 · see citing works

Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K

Villanueva, J., Vultur, A., Lee, J. T., Somasundaram, R., Fukunaga‐Kalabis, M., Cipolla, A. K., Wubbenhorst, B. S., Xu, X., Gimotty, P. A., Kee, D., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.023 · Cited by 1,261 · see citing works

Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and Stress

Sengupta, S., Peterson, T. R., & Sabatini, D. M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.026 · Cited by 1,234 · see citing works

Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1

Biggs, W., Meisenhelder, J., Hunter, T. R., Cavenee, W. K., & Arden, K. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7421 · Cited by 1,116 · see citing works

The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition

Meloche, S., & Pouysségur, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210414 · Cited by 1,091 · see citing works

Phosphorylation and Regulation of Raf by Akt (Protein Kinase B)

Zimmermann, S., & Moelling, K. (1999) · Science · doi:10.1126/science.286.5445.1741 · Cited by 1,088 · see citing works

Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A

Fang, X., Yu, S. X., Lu, Y., Bast, R. C., Woodgett, J. R., & Mills, G. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220413597 · Cited by 833 · see citing works

Phosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B*

Rena, G., Guo, S., Cichy, S. C., Unterman, T., & Cohen, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17179 · Cited by 787 · see citing works

Ribosomal protein S6 phosphorylation: from protein synthesis to cell size

Ruvinsky, I., & Meyuhas, O. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.04.003 · Cited by 780 · see citing works

The RSK family of kinases: emerging roles in cellular signalling

Anjum, R., & Blenis, J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2509 · Cited by 777 · see citing works

Negative Regulation of the Forkhead Transcription Factor FKHR by Akt

Tang, E., Núñez, G., Barr, F. G., & Guan, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.16741 · Cited by 761 · see citing works

Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase

Roux, P. P., Ballif, B. A., Anjum, R., Gygi, S. P., & Blenis, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405659101 · Cited by 750 · see citing works

RAS/ERK Signaling Promotes Site-specific Ribosomal Protein S6 Phosphorylation via RSK and Stimulates Cap-dependent Translation

Roux, P. P., Shahbazian, D., Vu, H., Holz, M. K., Cohen, M. S., Taunton, J., Sonenberg, N., & Blenis, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700906200 · Cited by 749 · see citing works

PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase

Chung, J., Grammar, T. C., Lemon, K. P., Kazlauskas, A., & Blenis, J. (1994) · Nature · doi:10.1038/370071a0 · Cited by 719 · see citing works

ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

Yang, J.-Y., Zong, C. S., Xia, W., Yamaguchi, H., Ding, Q., Xie, X., Lang, J.-Y., Lai, C., Chang, C. J., Huang, W., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1676 · Cited by 698 · see citing works

Crystal Structure of Glycogen Synthase Kinase 3β

Dajani, R., Fraser, E., Roe, S. M., Young, N., Good, V. M., Dale, T. C., & Pearl, L. H. (2001) · Cell · doi:10.1016/s0092-8674(01)00374-9 · Cited by 678 · see citing works

Phosphorylation and Inactivation of BAD by Mitochondria-Anchored Protein Kinase A

Harada, H., Becknell, B., Wilm, M. S., Mann, M., Huang, L. J.-S., Taylor, S. S., Scott, J. D., & Korsmeyer, S. J. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80469-4 · Cited by 645 · see citing works

Integrating signals from RTKs to ERK/MAPK

Mckay, M., & Morrison, D. K. (2007) · Oncogene · doi:10.1038/sj.onc.1210394 · Cited by 616 · see citing works

Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin

Ding, Q., Xia, W., Liu, J.-C., Yang, J.-Y., Lee, D.-F., Xia, J., Bartholomeusz, G., Li, Y., Pan, Y., Li, Z., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.009 · Cited by 597 · see citing works

Mitogen inactivation of glycogen synthase kinase-3β in intact cells via serine 9 phosphorylation

Stambolic, V., & Woodgett, J. R. (1994) · Biochemical Journal · doi:10.1042/bj3030701 · Cited by 581 · see citing works

p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD

Harada, H., Andersen, J., Mann, M., Terada, N., & Korsmeyer, S. (2001) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.171301998 · Cited by 563 · see citing works

Determination of the Specific Substrate Sequence Motifs of Protein Kinase C Isozymes

Nishikawa, K., Toker, A., Johannes, F., Songyang, Z., & Cantley, L. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.952 · Cited by 557 · see citing works

A Method to Identify Serine Kinase Substrates

Kane, S., Sano, H., Liu, S. C. H., Asara, J. M., Lane, W. S., Garner, C. C., & Lienhard, G. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200198200 · Cited by 529 · see citing works

Activation of phosphatidylinositol 3-kinase by insulin.

Ruderman, N. B., Kapeller, R., White, M. F., & Cantley, L. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1411 · Cited by 511 · see citing works

p27 Kip1 modulates cell migration through the regulation of RhoA activationPreprint

Besson, A., Gurian-West, M., Schmidt, A., Hall, A., & Roberts, J. M. (2004) · Genes & Development · doi:10.1101/gad.1185504 · Cited by 487 · see citing works

In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models

Hoeflich, K. P., O'Brien, C. L., Boyd, Z. S., Cavet, G., Guerrero, S., Jung, K., Januario, T., Savage, H. M., Punnoose, E. A., Truong, T., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0317 · Cited by 467 · see citing works

Mitogenic signaling pathways induced by G protein‐coupled receptors

Rozengurt, E. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21246 · Cited by 461 · see citing works

mTORC1-Activated S6K1 Phosphorylates Rictor on Threonine 1135 and Regulates mTORC2 Signaling

Julien, L.-A., Carriere, A., Moreau, J., & Roux, P. P. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00601-09 · Cited by 433 · see citing works

Differential Regulation of Glycogen Synthase Kinase 3β by Insulin and Wnt Signaling

Ding, V. W., Chen, R., & McCormick, F. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005342200 · Cited by 428 · see citing works

Characterization of Rictor Phosphorylation Sites Reveals Direct Regulation of mTOR Complex 2 by S6K1

Dibble, C. C., Asara, J. M., & Manning, B. D. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00735-09 · Cited by 420 · see citing works

The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells

She, Q., Solit, D. B., Ye, Q., O'Reilly, K. E., Lobo, J. M., & Rosen, N. X. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.006 · Cited by 416 · see citing works

4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in Tumors

She, Q.-B., Halilovic, E., Ye, Q., Zhen, W., Shirasawa, S., Sasazuki, T., Solit, D. B., & Rosen, N. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.05.023 · Cited by 400 · see citing works

Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes.

Goode, N. T., Hughes, K., Woodgett, J. R., & Parker, P. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41866-2 · Cited by 397 · see citing works

Regulation of Raf-Akt Cross-talk

Moelling, K., Schad, K., Bosse, M., Zimmermann, S., & Schweneker, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111974200 · Cited by 389 · see citing works

Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model

Kinkade, C. W., Castillo-Martín, M., Puzio‐Kuter, A. M., Yan, J., Foster, T. H., Gao, H., Sun, Y., Ouyang, X., Gerald, W. L., Cordon‐Cardo, C., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34764 · Cited by 388 · see citing works

Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition

Mirzoeva, O. K., Das, D., Heiser, L. M., Bhattacharya, S., Siwak, D. R., Gendelman, R., Bayani, N., Wang, N. J., Neve, R. M., Guan, Y., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3389 · Cited by 387 · see citing works

Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K.

Sun, M., Paciga, J. E., Feldman, R. I., Yuan, Z., Coppola, D., Lu, Y., Shelley, S. A., Nicosia, S. V., & Cheng, J. Q. (2001) · PubMed · Cited by 361 · see citing works

Akt-dependent Phosphorylation of p27Kip1Promotes Binding to 14-3-3 and Cytoplasmic Localization

Fujita, N., Sato, S., Katayama, K., & Tsuruo, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203668200 · Cited by 360 · see citing works

A rapid method for determining protein kinase phosphorylation specificity

Hutti, J. E., Jarrell, E. T., Chang, J. D., Abbott, D. W., Störz, P., Toker, A., Cantley, L. C., & Turk, B. E. (2004) · Nature Methods · doi:10.1038/nmeth708 · Cited by 356 · see citing works

pp90rsk1 Regulates Estrogen Receptor-Mediated Transcription through Phosphorylation of Ser-167

Joel, P. B., Smith, J. A., Sturgill, T. W., Fisher, T. L., Blenis, J., & Lannigan, D. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.1978 · Cited by 345 · see citing works

Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus

Nicolantonio, F. D., Arena, S., Tabernero, J. M., Grosso, S., Molinari, F., Macarulla, T. M., Russo, M., Cancelliere, C., Zecchin, D., Mazzucchelli, L., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci37539 · Cited by 343 · see citing works

The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK–ERK pathway to late endosomes

Nada, S., Hondo, A., Kasai, A., Koike, M., Saito, K., Uchiyama, Y., & Okada, M. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.308 · Cited by 341 · see citing works

The activation of phosphatidylinositol 3-kinase by Ras

Kodaki, T., Woscholski, R., Hallberg, B., Rodriguez-Viciana Julian Downward, P., & Parker, P. J. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00177-9 · Cited by 329 · see citing works

Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1

Vadlamudi, R. K., Feng, L., Adam, L., Nguyen, D. N., Ohta, Y., Stossel, T. P., & Kumar, R. (2002) · Nature Cell Biology · doi:10.1038/ncb838 · Cited by 321 · see citing works

Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells

Sutherland, B. W., Kucab, J. E., Wu, J., Lee, C., Cheang, M. C. U., Yorida, E., Turbin, D. A., Dedhar, S., Nelson, C. C., Pollak, M., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208590 · Cited by 299 · see citing works

Rsk1 mediates a MEK–MAP kinase cell survival signal

Shimamura, A., Ballif, B. A., Richards, S. A., & Blenis, J. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00310-9 · Cited by 296 · see citing works

The 70 kDa S6 Kinase Complexes with and Is Activated by the Rho Family G Proteins Cdc42 and Rac1

Chou, M. M., & Blenis, J. (1996) · Cell · doi:10.1016/s0092-8674(00)81257-x · Cited by 292 · see citing works

Receptor-Specific Regulation of Phosphatidylinositol 3′-Kinase Activation by the Protein Tyrosine Phosphatase Shp2

Zhang, S. Q., Tsiaras, W. G., Araki, T., Wen, G., Minichiello, L., Klein, R., & Neel, B. G. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4062-4072.2002 · Cited by 283 · see citing works

Negative Regulation of the Serine/Threonine Kinase B-Raf by Akt

Guan, K., Figueroa‐Romero, C., Brtva, T. R., Zhu, T., Taylor, J., Barber, T. D., & Vojtek, A. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004371200 · Cited by 281 · see citing works

Regulation of Raf‐1 activation and signalling by dephosphorylation

Dhillon, A. S., Meikle, S., Yazıcı, Z. A., Eulitz, M., & Kölch, W. (2002) · The EMBO Journal · doi:10.1093/emboj/21.1.64 · Cited by 280 · see citing works

ERK1/2 Phosphorylate Raptor to Promote Ras-dependent Activation of mTOR Complex 1 (mTORC1)

Carriere, A., Romeo, Y., Acosta-Jaquez, H. A., Moreau, J., Bonneil, E., Thibault, P., Fingar, D. C., & Roux, P. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.159046 · Cited by 268 · see citing works

Akt-Mediated YB-1 Phosphorylation Activates Translation of Silent mRNA Species

Evdokimova, V. E., Ruzanov, P., Anglesio, M. S., Sorokin, A. V., Ovchinnikov, L. P., Buckley, J. D., Triche, T. J., Sonenberg, N., & Sorensen, P. H. B. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.277-292.2006 · Cited by 259 · see citing works

Protein Kinase A Blocks Raf-1 Activity by Stimulating 14-3-3 Binding and Blocking Raf-1 Interaction with Ras

Dumaz, N., & Marais, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300182200 · Cited by 254 · see citing works

mTOR-Raptor Binds and Activates SGK1 to Regulate p27 Phosphorylation

Hong, F., Larrea, M. D., Doughty, C. A., Kwiatkowski, D. J., Squillace, R. M., & Slingerland, J. M. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.027 · Cited by 252 · see citing works

Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1

Zhu, J., Blenis, J., & Yuan, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802785105 · Cited by 246 · see citing works

p90RSK Blocks Bad-mediated Cell Death via a Protein Kinase C-dependent Pathway

Tan, Y., Ruan, H., Demeter, M. R., & Comb, M. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34859 · Cited by 241 · see citing works

The α‐isoform of glycogen synthase kinase‐3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase‐activated protein kinase‐1 in vitro

Sutherland, C. D., & Cohen, P. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80112-6 · Cited by 238 · see citing works

Evidence That Ser87 of BimEL Is Phosphorylated by Akt and Regulates BimEL Apoptotic Function

Qi, X.-J., Wildey, G. M., & Howe, P. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505546200 · Cited by 234 · see citing works

Cyclic AMP-Dependent Kinase Regulates Raf-1 Kinase Mainly by Phosphorylation of Serine 259

Dhillon, A. S., Pollock, C. B., Steen, H., Shaw, P. E., Mischak, H., & Kölch, W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3237-3246.2002 · Cited by 230 · see citing works

Phosphorylation of p27Kip1 at Threonine 198 by p90 Ribosomal Protein S6 Kinases Promotes Its Binding to 14-3-3 and Cytoplasmic Localization

Fujita, N., Sato, S., & Tsuruo, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306614200 · Cited by 210 · see citing works

PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model

Weng, L. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.6.605 · Cited by 199 · see citing works

Akt3 and Mutant V600EB-Raf Cooperate to Promote Early Melanoma Development

Cheung, M., Sharma, A. K., Madhunapantula, S. V., & Robertson, G. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5867 · Cited by 196 · see citing works

Regulation of mTOR Complex 1 (mTORC1) by Raptor Ser863 and Multisite Phosphorylation

Foster, K. G., Acosta-Jaquez, H. A., Roméo, Y., Üstünel, B. E., Soliman, G. A., Carriere, A., Roux, P. P., Ballif, B. A., & Fingar, D. C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.029637 · Cited by 191 · see citing works

New Insights into mTOR Signaling: mTORC2 and Beyond

Alessi, D. R., Pearce, L. R., & García‐Martínez, J. M. (2009) · Science Signaling · doi:10.1126/scisignal.267pe27 · Cited by 188 · see citing works

The Extracellular Signal-regulated Kinase Pathway Regulates the Phosphorylation of 4E-BP1 at Multiple Sites

Herbert, T. P., Tee, A. R., & Proud, C. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110367200 · Cited by 181 · see citing works

Regulation of multisite phosphorylation and 14-3-3 binding of AS160 in response to IGF-1, EGF, PMA and AICAR

Geraghty, K. M., Chen, S., Harthill, J. E., Ibrahim, A. F., Toth, R., Morrice, N. A., Vandermoere, F., Moorhead, G. B., Hardie, D. G., & MacKintosh, C. (2007) · Biochemical Journal · doi:10.1042/bj20070649 · Cited by 181 · see citing works

Ribosomal S6 Kinase (RSK) Regulates Phosphorylation of Filamin A on an Important Regulatory Site

Woo, M. S., Ohta, Y., Rabinovitz, I., Stossel, T. P., & Blenis, J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.3025-3035.2004 · Cited by 179 · see citing works

Function, regulation and pathological roles of the Gab/DOS docking proteins

Wöhrle, F. U., Daly, R. J., & Brummer, T. (2009) · Cell Communication and Signaling · doi:10.1186/1478-811x-7-22 · Cited by 171 · see citing works

Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells

Stratford, A. L., Fry, C. J., Desilets, C., Davies, A., Cho, Y. Y., Li, Y. Y., Dong, Z., Berquin, I. M., Roux, P. P., & Dunn, S. E. (2008) · Breast Cancer Research · doi:10.1186/bcr2202 · Cited by 156 · see citing works

Rictor is a novel target of p70 S6 kinase-1

Treins, C., Warne, P. H., Magnuson, M. A., Pende, M., & Downward, J. (2009) · Oncogene · doi:10.1038/onc.2009.401 · Cited by 154 · see citing works

ERK Negatively Regulates the Epidermal Growth Factor-mediated Interaction of Gab1 and the Phosphatidylinositol 3-Kinase

Yu, C. F., Liu, Z., & Cantley, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200732200 · Cited by 149 · see citing works

RSK1 drives p27 Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility

Larrea, M. D., Hong, F., Wander, S. A., Silva, T. G. D., Helfman, D. M., Lannigan, D. A., Smith, J. A., & Slingerland, J. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805057106 · Cited by 147 · see citing works

KSR2 Is an Essential Regulator of AMP Kinase, Energy Expenditure, and Insulin Sensitivity

Costanzo-Garvey, D. L., Pfluger, P. T., Dougherty, M. K., Stock, J. L., Boehm, M. B., Chaika, O. V., Fernandez, M. R., Fisher, K. W., Kortum, R. L., Hong, E., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.09.010 · Cited by 145 · see citing works

mTOR/S6K1 and MAPK/RSK signaling pathways coordinately regulate estrogen receptor α serine 167 phosphorylation

Yamnik, R. L., & Holz, M. K. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.11.041 · Cited by 143 · see citing works

KSR2 Is a Calcineurin Substrate that Promotes ERK Cascade Activation in Response to Calcium Signals

Dougherty, M. K., Ritt, D. A., Zhou, M., Specht, S. I., Monson, D. M., Veenstra, T. D., & Morrison, D. K. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.001 · Cited by 129 · see citing works

Activation of Phosphoinositide 3-Kinase γ by Ras

Suire, S., Hawkins, P. T., & Stephens, L. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00933-8 · Cited by 116 · see citing works

Signalling to cancer cell invasion through PAK family kinases

Whale, A. D. (2010) · Frontiers in bioscience · doi:10.2741/3724 · Cited by 101 · see citing works

p90 Ribosomal S6 Kinase and p70 Ribosomal S6 Kinase Link Phosphorylation of the Eukaryotic Chaperonin Containing TCP-1 to Growth Factor, Insulin, and Nutrient Signaling

Abe, Y., Yoon, S.-O., Kubota, K., Mendoza, M. C., Gygi, S. P., & Blenis, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900097200 · Cited by 90 · see citing works

Role of protein kinase B and the MAP kinase cascade in mediating the EGF‐dependent inhibition of glycogen synthase kinase 3 in Swiss 3T3 cells1

Shaw, M., & Cohen, P. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01434-9 · Cited by 88 · see citing works

Phosphorylation of p27Kip1 at Thr-157 Interferes with Its Association with Importin α during G1 and Prevents Nuclear Re-entry

Shin, I., Rotty, J. D., Wu, F. Y., & Arteaga, C. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412367200 · Cited by 88 · see citing works

AGC kinases regulate phosphorylation and activation of eukaryotic translation initiation factor 4B

van Gorp, A. G. M., van der Vos, K. E., Brenkman, A. B., Bremer, A., van den Broek, N. J. F., Zwartkruis, F. J. T., Hershey, J. W. B., Burgering, B. M. T., Calkhoven, C. F., & Coffer, P. J. (2008) · Oncogene · doi:10.1038/onc.2008.367 · Cited by 86 · see citing works

Ran-Binding Protein 3 Phosphorylation Links the Ras and PI3-Kinase Pathways to Nucleocytoplasmic Transport

Yoon, S.-O., Shin, S., Liu, Y., Ballif, B. A., Woo, M. S., Gygi, S. P., & Blenis, J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.12.024 · Cited by 80 · see citing works

Peptide growth factors signal differentially through protein kinase C to extracellular signal-regulated kinases in neonatal cardiomyocytes

Clerk, A., Aggeli, I.-K. S., Σταθοπούλου, Κ., & Sugden, P. H. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.04.005 · Cited by 74 · see citing works

Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration

Ravid, D., Chuderland, D., Landsman, L., Lavie, Y., Reich, R., & Liscovitch, M. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.06.004 · Cited by 73 · see citing works

Identification of Major ERK-Related Phosphorylation Sites in Gab1

Lehr, S., Kotzka, J., Avci, H., Sickmann, A., Meyer, H. E., Herkner, A., & Müller‐Wieland, D. (2004) · Biochemistry · doi:10.1021/bi049753e · Cited by 61 · see citing works

Protection from Rapamycin-Induced Apoptosis by Insulin-Like Growth Factor-I Is Partially Dependent on Protein Kinase C Signaling

Thimmaiah, K. N., Easton, J. B., & Houghton, P. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3693 · Cited by 18 · see citing works

AKT/PKB Signaling: Navigating the Network

Manning, B. D., & Toker, A. (2017) · Cell · doi:10.1016/j.cell.2017.04.001 · Cited by 3,772 · see citing works

ERK1/2 MAP kinases: Structure, function, and regulation

Roskoski, R. J. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.04.005 · Cited by 1,642 · see citing works

Reprogramming of fatty acid metabolism in cancer

Koundouros, N., & Poulogiannis, G. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0650-z · Cited by 1,621 · see citing works

The Transcription Factor TFEB Links mTORC1 Signaling to Transcriptional Control of Lysosome Homeostasis

Roczniak-Ferguson, A., Petit, C. S. V., Froehlich, F., Qian, S., Ky, J., Angarola, B. L., Walther, T. C., & Ferguson, S. M. (2012) · Science Signaling · doi:10.1126/scisignal.2002790 · Cited by 1,358 · see citing works

Rapamycin: one drug, many effects

Li, J., Kim, S. G., & Blenis, J. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.001 · Cited by 1,287 · see citing works

A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer

Braicu, C., Buse, M., Busuioc, C. I., Drulă, R., Gulei, D., Ráduly, L., Alexandru Vasile, R. U. S. U., Irimie, A., Atanasov, A. G., Slaby, O., et al. (2019) · Cancers · doi:10.3390/cancers11101618 · Cited by 940 · see citing works

Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer

Yu, L., Wei, J., & Liu, P. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.019 · Cited by 785 · see citing works

The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling

Shorning, B. Y., Dass, M. S., Smalley, M. J., & Pearson, H. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124507 · Cited by 638 · see citing works

Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy

Abdel-Wahab, A. F., Mahmoud, W., & Al-Harizy, R. M. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104511 · Cited by 589 · see citing works

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy

Tian, T., Li, X., & Zhang, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030755 · Cited by 581 · see citing works

mTOR complex 2 signaling and functions

Oh, W. J., & Jacinto, E. (2011) · Cell Cycle · doi:10.4161/cc.10.14.16586 · Cited by 561 · see citing works

Using Optogenetics to Interrogate the Dynamic Control of Signal Transmission by the Ras/Erk Module

Toettcher, J. E., Weiner, O. D., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.11.004 · Cited by 539 · see citing works

Ubiquitin ligases in oncogenic transformation and cancer therapy

Senft, D., Qi, J., & Ronai, Z. A. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.105 · Cited by 490 · see citing works

Airway microbiota is associated with upregulation of the PI3K pathway in lung cancer

Tsay, J.-C. J., Wu, B. G., Badri, M. H., Clemente, J. C., Shen, N., Meyn, P., Li, Y., Yie, T.-A., Lhakhang, T., Olsen, E., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201710-2118oc · Cited by 448 · see citing works

Endoplasmic Reticulum Stress in Malignancy

Clarke, H. J., Chambers, J. E., Liniker, E., & Marciniak, S. J. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.015 · Cited by 461 · see citing works

Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer

Liu, G., Pei, F., Yang, F., Li, L., Amin, A. D., Liu, S., Buchan, J. R., & Cho, W. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020367 · Cited by 424 · see citing works

Obesity and Cancer Mechanisms: Cancer Metabolism

Hopkins, B. D., Goncalves, M. D., & Cantley, L. C. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.9712 · Cited by 414 · see citing works

Stress granules, P-bodies and cancer

Anderson, P., Kedersha, N., & Ivanov, P. V. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.11.009 · Cited by 396 · see citing works

The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer

Slomovitz, B. M., & Coleman, R. L. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0662 · Cited by 398 · see citing works

NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer

Chio, I. I. C., Jafarnejad, S. M., Ponz-Sarvise, M., Park, Y., Rivera, K., Palm, W., Wilson, J., Sangar, V., Hao, Y., Öhlund, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.056 · Cited by 378 · see citing works

Comparison of cancer cells cultured in 2D vs 3D reveals differences in AKT/mTOR/S6-kinase signaling and drug response

Riedl, A., Schlederer, M., Pudelko, K., Stadler, M., Walter, S., Unterleuthner, D., Unger, C., Kramer, N., Hengstschläger, M., Kenner, L., et al. (2016) · Journal of Cell Science · doi:10.1242/jcs.188102 · Cited by 389 · see citing works

CCL5/CCR5 axis in human diseases and related treatments

Zeng, Z., Lan, T., Wei, Y., & Wei, X. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.08.004 · Cited by 382 · see citing works

mTOR Controls Mitochondrial Dynamics and Cell Survival via MTFP1

Morita, M., Prudent, J., Basu, K., Goyon, V., Katsumura, S., Hulea, L., Pearl, D., Siddiqui, N., Strack, S., McGuirk, S., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.08.013 · Cited by 368 · see citing works

The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells

Nepstad, I., Hatfield, K. J., Grønningsæter, I. S., & Reikvam, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082907 · Cited by 350 · see citing works

Ten things you should know about protein kinases: IUPHAR R eview 14

Fabbro, D., Cowan‐Jacob, S. W., & Möbitz, H. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13096 · Cited by 350 · see citing works

Dual or multi-targeting inhibitors: The next generation anticancer agents

Raghavendra, N. M., Pingili, D., Kadasi, S., Mettu, A., & Prasad, S. V. U. M. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.10.021 · Cited by 333 · see citing works

Targeting the PI3-kinase pathway in triple-negative breast cancer

Pascual, J., & Turner, N. C. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz133 · Cited by 330 · see citing works

Nutrient regulation of mTORC1 at a glance

Condon, K. J., & Sabatini, D. (2019) · Journal of Cell Science · doi:10.1242/jcs.222570 · Cited by 288 · see citing works

Growing knowledge of the mTOR signaling network

Huang, K., & Fingar, D. C. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.09.011 · Cited by 301 · see citing works

Selective Insulin and Leptin Resistance in Metabolic Disorders

Könner, A. C., & Brüning, J. C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.004 · Cited by 304 · see citing works

Signaling pathways in cancer metabolism: mechanisms and therapeutic targets

You, M., Xie, Z., Zhang, N., Zhang, Y., Xiao, D., Liu, S., Zhuang, W., Li, L., & Tao, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01442-3 · Cited by 297 · see citing works

The Circadian Clock Coordinates Ribosome Biogenesis

Jouffe, C., Cretenet, G., Symul, L., Martín, E., Atger, F., Naef, F., & Gachon, F. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001455 · Cited by 292 · see citing works

Regulation of Cell Cycle Progression by Growth Factor-Induced Cell Signaling

Wang, Z. (2021) · Cells · doi:10.3390/cells10123327 · Cited by 292 · see citing works

TSC1 controls macrophage polarization to prevent inflammatory disease

Zhu, L., Yang, T., Li, L., Sun, L., Hou, Y., Hu, X., Zhang, L., Tian, H., Zhao, Q., Peng, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms5696 · Cited by 285 · see citing works

Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma

Zhai, B., Hu, F., Jiang, X. L., Xu, J., Zhao, D., Liu, B., Pan, S., Dong, X., Tan, G., Wei, Z., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-1043 · Cited by 286 · see citing works

Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma

Sun, E. J., Wankell, M., Palamuthusingam, P., McFarlane, C., & Hebbard, L. (2021) · Biomedicines · doi:10.3390/biomedicines9111639 · Cited by 287 · see citing works

Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy

Li, Q., Li, Z., Luo, T. L., & Shi, H. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00110-2 · Cited by 274 · see citing works

Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming

Adeshakin, F. O., Adeshakin, A. O., Afolabi, L. O., Yan, D., Zhang, G., & Wan, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.626577 · Cited by 271 · see citing works

Nutrient Regulation of the mTOR Complex 1 Signaling Pathway

Kim, S. G., Buel, G. R., & Blenis, J. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0138-2 · Cited by 259 · see citing works

A Comprehensive Review of HER2 in Cancer Biology and Therapeutics

Cheng, X. (2024) · Genes · doi:10.3390/genes15070903 · Cited by 258 · see citing works

Mechanistic Target of Rapamycin–Independent Antidepressant Effects of ( R )-Ketamine in a Social Defeat Stress Model

Yang, C., Ren, Q., Qu, Y., Zhang, J., Ma, M., Dong, C., & Hashimoto, K. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.05.016 · Cited by 252 · see citing works

Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapyPreprint

Logue, J. S., & Morrison, D. K. (2012) · Genes & Development · doi:10.1101/gad.186965.112 · Cited by 252 · see citing works

Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis

Xu, X., Fan, Z., Kang, L., Han, J., Jiang, C., Zheng, X., Zhu, Z., Jiao, H., Lin, J., Jiang, K., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64265 · Cited by 249 · see citing works

Concepts in Boolean network modeling: What do they all mean?

Schwab, J. D., Werle, S. D., Ikonomi, N., Kühl, M., & Kestler, H. A. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.03.001 · Cited by 249 · see citing works

Ketamine: A tale of two enantiomers

Jelen, L. A., Young, A. H., & Stone, J. M. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120959644 · Cited by 253 · see citing works

Mitochondrial sirtuins, metabolism, and aging

Ji, Z., Liu, G., & Qu, J. T. (2021) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2021.11.005 · Cited by 246 · see citing works

Lymphatic Malformations: Genetics, Mechanisms and Therapeutic Strategies

Mäkinen, T., Boon, L. M., Vikkula, M., & Alitalo, K. K. (2021) · Circulation Research · doi:10.1161/circresaha.121.318142 · Cited by 237 · see citing works

The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis

Woodcock, H. V., Eley, J. D., Guillotin, D., Platé, M., Nanthakumar, C. B., Martufi, M., Peace, S., Joberty, G., Poeckel, D., Good, R. B., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07858-8 · Cited by 224 · see citing works

AKT and ERK dual inhibitors: The way forward?

Cao, Z., Liao, Q., Su, M., Huang, K., Jin, J., & Cao, D. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.05.025 · Cited by 234 · see citing works

Targeting mTOR and Metabolism in Cancer: Lessons and Innovations

Magaway, C., Kim, E., & Jacinto, E. (2019) · Cells · doi:10.3390/cells8121584 · Cited by 225 · see citing works

Chemoresistance and targeted therapies in ovarian and endometrial cancers

Brasseur, K., Gévry, N. Y., & Asselin, É. (2016) · Oncotarget · doi:10.18632/oncotarget.14021 · Cited by 224 · see citing works

Innate Immune Programing by Endotoxin and Its Pathological Consequences

Morris, M. C., Gilliam, E. A., & Li, L. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00680 · Cited by 224 · see citing works

Post-transcriptional Regulation of De Novo Lipogenesis by mTORC1-S6K1-SRPK2 Signaling

Lee, G., Zheng, Y., Cho, S., Jang, C., England, C., Dempsey, J. M., Yu, Y., Liu, X., He, L., Cavaliere, P. M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.037 · Cited by 222 · see citing works

PI3K and MEK inhibitor combinations: examining the evidence in selected tumor types

Britten, C. D. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2121-1 · Cited by 216 · see citing works

Impaired ribosome biogenesis: mechanisms and relevance to cancer and aging

Turi, Z., Lacey, M., Mistrík, M., & Moudrý, P. (2019) · Aging · doi:10.18632/aging.101922 · Cited by 209 · see citing works

Mechanisms and pathways of growth failure in primordial dwarfism.Preprint

Klingseisen, A., & Jackson, A. P. (2011) · Genes & Development · doi:10.1101/gad.169037 · Cited by 237 · see citing works

Chemoresistance and the Self-Maintaining Tumor Microenvironment

Yeldag, G., Rice, A. J., & Hernández, A. E. D. R. (2018) · Cancers · doi:10.3390/cancers10120471 · Cited by 211 · see citing works

Activation of the EGF Receptor by Ligand Binding and Oncogenic Mutations: The “Rotation Model”

Purba, E. R., Saita, E., & MARUYAMA, I. N. (2017) · Cells · doi:10.3390/cells6020013 · Cited by 201 · see citing works

PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer

Li, H., Zeng, J., & Shen, K. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3377-3 · Cited by 203 · see citing works

Targeted Therapy in Melanoma and Mechanisms of Resistance

Czarnecka, A. M., Bartnik, E., Fiedorowicz, M., & Rutkowski, P. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134576 · Cited by 199 · see citing works

Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A

Fledrich, R., Stassart, R. M., Klink, A., Rasch, L. M., Prukop, T., Haag, L. M., Czesnik, D., Kungl, T., Abdelaal, T. A., Keric, N., et al. (2014) · Nature Medicine · doi:10.1038/nm.3664 · Cited by 196 · see citing works

Translational control of stem cell function

Saba, J. A., Liakath‐Ali, K., Green, R., & Watt, F. M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00386-2 · Cited by 200 · see citing works

mTOR Signaling in Protein Translation Regulation: Implications in Cancer Genesis and Therapeutic Interventions

Showkat, M., Beigh, M. A., & Andrabi, K. I. (2014) · Molecular Biology International · doi:10.1155/2014/686984 · Cited by 191 · see citing works

MEK inhibitor resistance mechanisms and recent developments in combination trials

Kun, E., Tsang, Y. T. M., Ng, C. W., Gershenson, D. M., & Wong, K. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102137 · Cited by 189 · see citing works

mTORC1 stimulates cell growth through SAM synthesis and m6A mRNA-dependent control of protein synthesis

Villa, E., Sahu, U., O’Hara, B. P., Ali, E. S., Helmin, K. A., Asara, J. M., Gao, P., Singer, B. D., & Ben‐Sahra, I. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.03.009 · Cited by 186 · see citing works

KRAS G12C Game of Thrones, which direct KRAS inhibitor will claim the iron throne?

Nagasaka, M., Li, Y., Sukari, A., Ou, S.-H. I., Al-Hallak, M. N., & Azmi, A. S. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.101974 · Cited by 185 · see citing works

The Hallmarks of Flavonoids in Cancer

Ponte, L. G. S., Pavan, I. C. B., Mancini, M. C. S., da Silva, L. G. S., Morelli, A. P., Severino, M. B., Bezerra, R. M. N., & Simabuco, F. M. (2021) · Molecules · doi:10.3390/molecules26072029 · Cited by 184 · see citing works

Impaired insulin signalling and allostatic load in Alzheimer disease

Felice, F. G. D., Gonçalves, R. A., & Ferreira, S. T. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00558-9 · Cited by 180 · see citing works

The effects of metformin on autophagy

Lu, G., Wu, Z., Shang, J., Xie, Z., Chen, C., & zhang, C. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111286 · Cited by 179 · see citing works

Brain-Derived Neurotrophic Factor (BDNF): Novel Insights into Regulation and Genetic Variation

Notaras, M. J., & van den Buuse, M. (2018) · The Neuroscientist · doi:10.1177/1073858418810142 · Cited by 178 · see citing works

Extracellular Signal-Regulated Kinase: A Regulator of Cell Growth, Inflammation, Chondrocyte and Bone Cell Receptor-Mediated Gene Expression

Lu, N., & Malemud, C. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153792 · Cited by 176 · see citing works

‘Warburg effect’ controls tumor growth, bacterial, viral infections and immunity – Genetic deconstruction and therapeutic perspectives

Pouysségur, J., Marchiq, I., Parks, S. K., Durivault, J., Ždralević, M., & Vučetić, M. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.07.004 · Cited by 172 · see citing works

Crosstalk between ROR1 and the Pre-B Cell Receptor Promotes Survival of t(1;19) Acute Lymphoblastic Leukemia

Bicocca, V. T., Chang, B. H., Masouleh, B. K., Müschen, M., Loriaux, M., Druker, B. J., & Tyner, J. W. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.027 · Cited by 170 · see citing works

Shock Wave Treatment Enhances Cell Proliferation and Improves Wound Healing by ATP Release-coupled Extracellular Signal-regulated Kinase (ERK) Activation

Weihs, A. M., Fuchs, C., Teuschl, A., Hartinger, J., Slezak, P., Mittermayr, R., Redl, H. R., JUNGER, W. G., Sitte, H. H., & Rünzler, D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.580936 · Cited by 168 · see citing works

Insulin Resistance and Cancer: In Search for a Causal Link

CHIEFARI, E. D., Mirabelli, M., Vignera, S. L., Tanyolaç, S., FOTI, D. P., Aversa, A., & Brunetti, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011137 · Cited by 175 · see citing works

Ras/Raf/MEK/ERK pathway activation in childhood acute lymphoblastic leukemia and its therapeutic targeting

Knight, T., & Irving, J. A. E. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00160 · Cited by 164 · see citing works

Single-Cell Phosphoproteomics Resolves Adaptive Signaling Dynamics and Informs Targeted Combination Therapy in Glioblastoma

Wei, W., Shin, Y. S., Xue, M., Matsutani, T., Masui, K., Yang, H., Ikegami, S., Gu, Y., Herrmann, K., Johnson, D., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.012 · Cited by 169 · see citing works

Activating PIK3CA alleles and lymphangiogenic phenotype of lymphatic endothelial cells isolated from lymphatic malformations

Osborn, A. J., Dickie, P., Neilson, D., Glaser, K., Lynch, K. A., Gupta, A., & Dickie, B. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu505 · Cited by 166 · see citing works

PGE2 activates EP4 in subchondral bone osteoclasts to regulate osteoarthritis

Jiang, W.-H., Jin, Y.-Y., Zhang, S., Ding, Y., Huo, K., Yang, J., Zhao, L., Nian, B., Zhong, T., Lu, W.-Q., et al. (2022) · Bone Research · doi:10.1038/s41413-022-00201-4 · Cited by 155 · see citing works

Phytochemicals in cancer cell chemosensitization: Current knowledge and future perspectives

Khatoon, E., Banik, K., Harsha, C., Sailo, B. L., Thakur, K. K., Khwairakpam, A. D., Vikkurthi, R., Devi, T. B., Gupta, S. C., & Kunnumakkara, A. B. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.014 · Cited by 163 · see citing works

ERK1/2 inhibitors: New weapons to inhibit the RAS-regulated RAF-MEK1/2-ERK1/2 pathway

Kidger, A. M., Sipthorp, J., & Cook, S. J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.02.007 · Cited by 161 · see citing works

Targeting cancer by binding iron: Dissecting cellular signaling pathways

Lui, G. Y. L., Kovačević, Ž., Richardson, V., Merlot, A. M., Kalinowski, D. S., & Richardson, D. R. (2015) · Oncotarget · doi:10.18632/oncotarget.4349 · Cited by 163 · see citing works

Engineering an Artificial T‐Cell Stimulating Matrix for Immunotherapy

Hickey, J. W., Dong, Y. W., Chung, J. W., Salathe, S. F., Pruitt, H. C., Li, X., Chang, C. K. W., Fraser, A. K., Bessell, C. A., Ewald, A. J., et al. (2019) · Advanced Materials · doi:10.1002/adma.201807359 · Cited by 156 · see citing works

BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies

Spagnolo, F., Ghiorzo, P., Orgiano, L., Pastorino, L., Picasso, V., Tornari, E., Ottaviano, V., & Queirolo, P. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s39096 · Cited by 161 · see citing works

Diagnostic Pathology of Tumors of Peripheral Nerve

Belakhoua, S., & Rodríguez, F. J. (2021) · Neurosurgery · doi:10.1093/neuros/nyab021 · Cited by 160 · see citing works

Feedback and redundancy in receptor tyrosine kinase signaling: relevance to cancer therapies

Sun, C., & Bernards, R. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.08.010 · Cited by 155 · see citing works

eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies

Alain, T., Morita, M., Fonseca, B. D., Yanagiya, A., Siddiqui, N., Bhat, M., Zammit, D., Marcus, V., Metrakos, P. P., Voyer, L.-A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2395 · Cited by 158 · see citing works

Benefits of Lactoferrin, Osteopontin and Milk Fat Globule Membranes for Infants

Demmelmair, H., Prell, C., Timby, N., & Lönnerdal, B. L. (2017) · Nutrients · doi:10.3390/nu9080817 · Cited by 160 · see citing works

Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy

Felsenstein, K. M., & Theodorescu, D. (2017) · Nature Reviews Urology · doi:10.1038/nrurol.2017.179 · Cited by 159 · see citing works

The Opposing Roles of PIK3R1/p85α and PIK3R2/p85β in Cancer

Vallejo-Díaz, J., Chagoyen, M., Olazabal-Morán, M., González-Garcı́a, A., & Carrera, A. C. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.02.009 · Cited by 159 · see citing works

Crosstalk in Cellular Signaling: Background Noise or the Real Thing?

Vert, G., & Chory, J. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.11.006 · Cited by 154 · see citing works

The immunobiology of mTOR in autoimmunity

Suto, T., & Karonitsch, T. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102373 · Cited by 149 · see citing works

Cationic, anionic and neutral polysaccharides for skin tissue engineering and wound healing applications

Nosrati, H., Khodaei, M., Alizadeh, Z., & Banitalebi-Dehkordi, M. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.10.013 · Cited by 152 · see citing works

Multi-omic Profiling Reveals Dynamics of the Phased Progression of Pluripotency

Yang, P., Humphrey, S. J., Cinghu, S., Pathania, R., Oldfield, A. J., Kumar, D., Perera, D., Yang, J. Y. H., James, D. E., Mann, M., et al. (2019) · Cell Systems · doi:10.1016/j.cels.2019.03.012 · Cited by 146 · see citing works

Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis

Flex, E., Jaiswal, M., Pantaleoni, F., Martinelli, S., Strullu, M., Fansa, E. K., Caye‐Eude, A., Luca, A. D., Lepri, F. R., Dvorský, R., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu148 · Cited by 145 · see citing works

The Landscape of Atypical and Eukaryotic Protein Kinases

Kanev, G. K., de Graaf, C., de Esch, I. J. P., Leurs, R., Würdinger, T., Westerman, B. A., & Kooistra, A. J. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.09.002 · Cited by 143 · see citing works

Reviewing the Effects of l-Leucine Supplementation in the Regulation of Food Intake, Energy Balance, and Glucose Homeostasis

Pedroso, J. A. B., Zampieri, T. T., & Donato, J. (2015) · Nutrients · doi:10.3390/nu7053914 · Cited by 143 · see citing works

Targeting PI3K Signaling in Combination Cancer Therapy

Tostivint, E. P., Thibault, B., & Guillermet‐Guibert, J. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.04.002 · Cited by 141 · see citing works

Sorafenib resistance and JNK signaling in carcinoma during extracellular matrix stiffening

Nguyen, T. V., Sleiman, M., Moriarty, T., Herrick, W. G., & Peyton, S. R. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.058 · Cited by 141 · see citing works

mTOR signaling response to resistance exercise is altered by chronic resistance training and detraining in skeletal muscle

Ogasawara, R., Kobayashi, K., Tsutaki, A., Lee, K., Abe, T., Fujita, S., Nakazato, K., & Ishii, N. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01161.2012 · Cited by 138 · see citing works

Dynamic cross‐talk between PI3‐kinase/Akt and Ras/ERK pathways in EGF receptor signaling that can affect drug sensitivity in tumor cells

Aksamitiene, E., Kiyatkin, A. B., & Hoek, J. B. (2010) · The FASEB Journal · doi:10.1096/fasebj.24.1_supplement.715.2 · Cited by 1 · see citing works

Integration of AKT and ERK Signaling Pathways in Cancer: Biological and Therapeutic

She, Q. (2013)

Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance

Aksamitiene, E., Kiyatkin, A., & Kholodenko, B. N. (2012) · Biochemical Society Transactions · doi:10.1042/bst20110609 · Cited by 479 · see citing works

Cotargeting survival signaling pathways in cancer

Grant, S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36898 · Cited by 170 · see citing works

PI3K‐dependent cross‐talk interactions converge with Ras as quantifiable inputs integrated by Erk

Wang, C., Cirit, M., & Haugh, J. M. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.4 · Cited by 84 · see citing works